MYGN FY 2022 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$487M

FY 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$678M-1.8% YoY

Gross Profit

$476M70.2% margin

Operating Income

-$141M-20.7% margin

Net Income

-$112M-16.5% margin

EPS (Diluted)

$-1.39

Cash Flow

Operating Cash Flow

-$106M

Free Cash Flow

-$152M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$313M

Stockholders' Equity

$886M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$678M	$691M	-1.8%
Gross Profit	$476M	$493M	-3.4%
Operating Income	-$141M	-$191M	+26.2%
Net Income	-$112M	-$27M	-311.8%